Brief: Enlivex Therapeutics Files For Offering Of Up To $299.6 Mln Of Ordinary Shares
24/11/2025 18:15
Nov 24 (Reuters) - Enlivex Therapeutics Ltd ENLV.TA: ENLIVEX THERAPEUTICS LTD - FILES FOR OFFERING OF UP TO $299.6 MILLION OF ORDINARY SHARES - SEC FILING Source text: [ID:n0001213900-25-113879] Further company coverage: ENLV.TA ((((Reuters.Briefs@thomsonreuters.com));))
Recent news on Enlivex
See all newsBrief: Enlivex Ltd Registers Up To 23,333,333 Ordinary Shares For Resale By Selling Shareholder
Brief: Enlivex Announces Second Regulatory Approval For Phase 2B Trial Of Allocetra In Age-Related Primary Moderate-To-Severe Knee Osteoarthritis
Brief: Enlivex Therapeutics Files For Offering Of Up To $299.6 Mln Of Ordinary Shares
Brief: Enlivex Announces Positive 6-Month Topline Data For Patients with Knee Osteoarthritis
Brief: Enlivex Files Patent for Allocetra Use in Osteoarthritis Treatment